KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Explanation to Bollinger's Bands

Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.

Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.

Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation

BandWidth defines the current width of the band.
%b defines the current position within the band.

BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)

Live Samples:

Bollinger Bottleneck Buy Pattern 1
Bollinger Bottleneck Buy Pattern 2
Bollinger Bottleneck Sell Pattern

Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.

Source: http://www.bollingerbands.com

RSI low/high Values: [ 25 - 80 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of PVCT
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Green day on Thursday for Provectus Pharmaceuticals, Inc stock after gaining 1.24%
(Updated on Apr 25, 2024)

Buy or Hold candidate since Apr 17, 2024 Gain 3.37% PDF

The Provectus Pharmaceuticals, Inc stock price gained 1.24% on the last trading day (Thursday, 25th Apr 2024), rising from $0.194 to $0.196. During the last trading day the stock fluctuated 6.10% from a day low at $0.185 to a day high of $0.196. The price has risen in 5 of the last 10 days and is up by 7.97% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 183 thousand more shares were traded than the day before. In total, 251 thousand shares were bought and sold for approximately $49.30 thousand.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 41.98% during the next 3 months and, with a 90% probability hold a price between $0.227 and $0.355 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

PVCT Signals & Forecast

The Provectus Pharmaceuticals, Inc stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $0.194 and $0.188. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Provectus Pharmaceuticals, Inc has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. The very low volume increases the risk and reduces the other technical signals issued. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Friday, March 15, 2024, and so far it has fallen -9.43%. Further fall is indicated until a new bottom pivot has been found.

Support, Risk & Stop-loss for Provectus Pharmaceuticals, Inc stock

On the downside, the stock finds support just below today's level from accumulated volume at $0.180 and $0.170. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Provectus Pharmaceuticals, Inc finds support just below today's level at $0.180. If this is broken, then the next support from accumulated volume will be at $0.170 and $0.169.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.0113 between high and low, or 6.10%. For the last week, the stock has had daily average volatility of 5.21%.

Our recommended stop-loss: $0.187 (-4.97%) (This stock has high daily movements and this gives high risk. There is a sell signal from a pivot top found 28 days ago.)

Trading Expectations (PVCT) For The Upcoming Trading Day Of Friday 26th

For the upcoming trading day on Friday, 26th we expect Provectus Pharmaceuticals, Inc to open at $0.193, and during the day (based on 14 day Average True Range), to move between $0.180 and $0.213, which gives a possible trading interval of +/-$0.0165 (+/-8.43%) up or down from last closing price. If Provectus Pharmaceuticals, Inc takes out the full calculated possible swing range there will be an estimated 16.85% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $0.199 (1.20%) than the support at $0.180 (8.40%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Provectus Pharmaceuticals, Inc stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Provectus Pharmaceuticals, Inc stock to perform well in the short-term.

Current score: 4.674 Buy Candidate Unchanged

Predicted Opening Price for Provectus Pharmaceuticals, Inc of Friday, April 26, 2024

Fair opening price April 26, 2024 Current price
$0.193 ( 1.92%) $0.196

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for PVCT

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.204 3.84 %
R2 0.200 1.64 %
R1 0.197 0.280 %
Current price: 0.196
Support S1 0.188 -4.12 %
S2 0.186 -5.47 %
S3 0.181 -7.67 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0.213 8.55 %
R2 0.200 1.83 %
R1 0.199 1.20 %
Current price 0.196
Support S1 0.180 -8.40%
S2 0.170 -13.44%
S3 0.169 -14.10%

FAQ

What is the symbol for Provectus Pharmaceuticals, Inc Stock and on which exchange is it traded?
The symbol for Provectus Pharmaceuticals, Inc is PVCT and it is traded on the NYSE (New York Stock Exchange).

Should I buy or sell Provectus Pharmaceuticals, Inc Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Provectus Pharmaceuticals, Inc stock to perform well in the short-term.

How to buy Provectus Pharmaceuticals, Inc Stock?
Provectus Pharmaceuticals, Inc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Provectus Pharmaceuticals, Inc Stock.

What's the current price of Provectus Pharmaceuticals, Inc Stock?
As of the end of day on the Apr 25, 2024, the price of an Provectus Pharmaceuticals, Inc (PVCT) share was $0.196.

What is the 52-week high and low for Provectus Pharmaceuticals, Inc Stock?
The 52-week high for Provectus Pharmaceuticals, Inc Stock is $0.225 and the 52-week low is $0.0560.

What is the market capitalization of Provectus Pharmaceuticals, Inc Stock?
As of the Apr 25, 2024, the market capitalization of Provectus Pharmaceuticals, Inc is 82.394M.

When is the next earnings date for Provectus Pharmaceuticals, Inc?
The upcoming earnings date for Provectus Pharmaceuticals, Inc is Jun 20, 2024.
Click to get the best stock tips daily for free!

About Provectus Pharmaceuticals, Inc

Provectus Pharmaceuticals Provectus Biopharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing immunotherapy medicines based on halogenated xanthenes. It develops PV-10, an investigational autolytic cancer immunotherapy for adult solid tumor cancers, such as melanoma and gastrointestinal tumors, including hepatocellular carcinoma; colorectal cancer metastatic to the liver; neuroendocrine tumors metastatic to the liver; uveal melanoma metastati... PVCT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT